Creative Medical Technology Holdings Inc — Liquidità (NASDAQ:CELZ)

Financials

Flusso di cassa derivante dalle attività operative -434.56 K-2.22 M-7.8 M-8.03 M-5.3 M-5.86 M -5.86 M Flussi di cassa derivanti dalle attività di investimento -250 K0-10.08 M3.45 M6.32 M-50.5 K -50.5 K Liquidità derivante dalle attività di finanziamento 693.92 K12.84 M15.47 M-270.95 K1.45 M7.17 M 7.17 M Liquidità libera -434.56 K-2.52 M-7.8 M-8.03 M-5.3 M-5.86 M -5.86 M

Notizie

Creative Medical riceve la designazione dell’OMS per la seconda terapia cellulare

Creative Medical receives WHO designation for second cell therapy

Creative Medical riporta dati intermedi positivi per terapia del dolore lombare

Creative Medical reports positive interim data for back pain therapy

Creative Medical’s BioDefense initiative receives regulatory approval

Gli azionisti di Creative Medical Technology approvano la proposta di esercizio dei warrant

Creative Medical Technology stockholders approve warrant exercise proposal

Creative Medical completes enrollment in chronic back pain trial

WHO approves olastrocel as international name for CELZ-201 therapy

Creative Medical Technology Holdings approva bonus per CEO e CFO

Creative Medical Technology Holdings approves bonuses for CEO and CFO

Bears are Losing Control Over Creative Medical Technology Holdings, Inc. (CELZ), Here's Why It's a 'Buy' Now